Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-04-30
2000-03-14
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530331, 530332, A61K 3806, C07K 5087, C07K 5097
Patent
active
060373253
ABSTRACT:
The present invention relates to certain substituted oxadiazole, thiadiazole and triazole peptoids which are useful as inhibitors of serine proteases including human neutrophil elastase, equivalently known as human leukocyte elastase.
REFERENCES:
patent: 4338453 (1982-07-01), Gall
patent: 5055450 (1991-10-01), Edwards et al.
patent: 5164371 (1992-11-01), Edwards et al.
patent: 5618792 (1997-04-01), Gyorkos et al.
patent: 5801148 (1998-09-01), Gyorkos et al.
patent: 5807829 (1998-09-01), Gyorkos et al.
patent: 5861380 (1999-01-01), Gyorkos et al.
patent: 5874585 (1999-02-01), Gyorkos et al.
Edwards, P. D. et al., "Peptidyl Alpha-Ketoheterocyclic inhibitor of Human Neutrophil Elastase. 3. In Vitro and in Vivo Potency of a Series of Peptidyl Alpha-Ketobenzoxazoles," J. Med. Chem. 38: 3972-3982 (1995).
Edwards, P. D. et al., "Nonpeptic Inhibitors of Human Neotrophil Elastase. 7. Design, Synthesis, and in Vitro Activity of a Series of Pyridopyrimidine Trifluoromethyl Ketones," J. Med. Chem. 39: 1112-1124 (1996).
Edwards, P. D. et al., "Petidyl Alpha-Ketoheterocyclic Inhibitors of Human Neutrophil Elastase. 2. Effect of Varying the Heterocyclic Ring on in Vitro Potency," J. Med Chem. 38: 76-85 (1995).
Veale, C. A. et al., "Non-peptidic Inhibitors of Human Leukocyte Elastase. 4. Design, Synthesis, and in Vitro and In Vivo Activity of a Series of Beta-Carbolinone-Containing Trifluoromethyl Ketones," J. Med. Chem. 38: 86-97 (1995).
Veale, C. A. et al., "Nonpeptidic Inhibitors of Human Leukocyte Elastase. 5. Design, Synthesis, and X-ray Crystallography ofa Series of Orally Active 5-Aminopyrimidin-6-one-Containing Trifluoromethyl Ketones," J. Med. Chem. 38: 98-108 (1995).
Goddard, C. J., "Antiinflammatory 1-Phenylpyrazole-4-Heteroarylalkanoic Acids," J. Heterocyclic Chem. 28: 1607-1612 (1991).
LaMattina, J. L. et al., "Utility of 24 p-Nitrophenyl 3-Bromo-2,2-diethoxypropionate (NPBDP) in Neterocyclic Synthesis," J. Org. Chem. 49: 4800-4805 (1984).
Unangst, P. C. et al., "Novel 1,2,4-Oxadiazoles and 1,2,4-Thiadiazoles as Dual 5-Lipoxygenase and Cycloioxygenase Inhibitors," J. Med. Chem. 35: 3691-3698 (1992).
Kitatani, K. et al., "A Novel Oxazole Synthesis Utilizing Tungsten(VI) Catalyzed Decomposition of Alpha-Diazo Carbonyl Compounds in Nitriles," Tet. Lett. 16: 1531-1532 (1974).
Wiley, R. H., "Chemistry of the Oxazoles," Chem. Rev. 37: 401-442 (1945).
Davidson, D. et al., "The Action of Ammonia on Bension," J. Org. Chem. 2: 328-334 (1937).
Wiegand, Edwin E. et al., "Polyphosphoric Acid Cyclization of Acetamidoketones to 2,5-Dimethyl-1,3-oxazoles," Synthesis 12: 648-649 (1970).
Wasserman, H.H. et al., "The Oxazole-Triamide Rearrangement. Application To Peptide Synthesis," Tet. Lett. 23(37): 3831-3834 (1982).
Comforth, J. W. et al., "A New Synthesis of Oxazoles and Iminazoles including its Application to the Preparation of Oxazole," J. Chem Soc. 96-102 (1947).
Comforth, J. W. et al., "Synthesis of Oxazoles from Ethyl Acetoacetate. Ring-fission of Some Oxazole-5-carboxylic Acids," J. Chem. Soc. 93-98 (1953).
Bernstein, P. R. et al., "Nonpeptidic Inhibitors of Human Leukocyte Elastase. 3. Design, Synthesis, X-Ray Crystallographic Analysis, and Structure--Activity Relationship for a Series of Orally Active 3-Amino-6-phenylpyridin-2-one Trifluoromethyl Ketones," J. Med. Chem. 37: 3313-3326 (1994).
Brown, F. J. et al., "Design of Orally Active, Non-Peptidic Inhibitors of Human Lekocyte Elastase," J. Med. Chem. 37: 1259-1261 (1994).
Warner, P. et al., "Non-peptidic Inhibitors of Human Leukocyte Elastase. 1. The Design and Synthesis of Pyridone-Containing Inhibitors," J. Med. Chem. 37: 3090-3099 (1994).
Budavari, Susan (Editor), "The Merck Index," An Encylopedia of Chemicals, Drugs, and Biologicals; Merck & Co., Inc.: 294 (1989).
Damewood, J. R., Jr. et al. "Nonpeptidic Inhibitors of Human Leukocyte Elastase. 2. Design, Synthesis, and in vitro Activity of Series of 3-Amino-6-arylopyridin-2-one Trifluormethyl Ketones," J. Med. Chem. 37: 3303-3312 (1994).
Browne, "Azole Aldehyde Condensations," Aust. J. Chem. 26: 1809-1814 (1973).
Skiles, J.W., et al. "Elastase Inhibitors Containing Conformationally Restricted Lactams as P.sub.3 -P.sub.2 Dipeptide Replacements," Bio. & Med. Chem. Ltrs. 3, 773-778 (1993).
Gyorkos Albert
Spruce Lyle W.
Cortech Inc.
Russel Jeffrey E.
LandOfFree
Substituted heterocyclic compounds useful as inhibitors of (seri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocyclic compounds useful as inhibitors of (seri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic compounds useful as inhibitors of (seri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-169227